EP293: Game Theory Gone Wild: Co-pay Cards, Co-pay Accumulators, and Co-pay Maximizers, With Dea Belazi, PharmD, MPH, President and CEO of AscellaHealth
Episode Description
In Episode 293, Stacey Richter talks with Dea Belazi, PharmD, MPH, president and CEO of AscellaHealth, about the escalating game theory battle among co-pay cards, co-pay accumulators, and co-pay maximizers.
WHAT YOU'LL LEARN
✅ How the "war of the co-pays" started when PBMs began demanding higher discounts from Pharma in exchange for lower patient co-pays
✅ Why pharma companies turned to co-pay discount cards to route around PBM leverage
✅ What co-pay accumulators and co-pay maximizers are, and how each escalates the fight differently
✅ Why this dynamic is far higher stakes on specialty drugs, where patients may have only one treatment option
✅ Why neither insurers nor pharma companies are truly innocent bystanders in what patients end up paying
WHY THIS MATTERS
Dea Belazi lays out an escalating game theory battle: PBMs use control over patient co-pays to extract discounts from Pharma, Pharma responds with co-pay discount cards to bypass PBMs, and PBMs counter with co-pay accumulators and maximizers that claw the value back. On expensive specialty drugs where patients may have only one viable option, this fight isn't academic — it determines whether people can actually afford care they're already paying premiums for. Belazi is careful to point out that both insurers, who set patient cost share, and pharma companies, who set drug prices, share responsibility for patients getting caught in the middle.
MENTIONED IN THIS EPISODE
=== LINKS ===
🔗 Show Notes with all mentioned links: Episode Page
🔗 Healthcare Industry Acronyms and Terms
✉️ Enjoy this podcast? Subscribe to the free weekly newsletter
🫙 Support the podcast with a small donation to the Tip Jar
📺 Subscribe to our YouTube channel
🎤 Listen on Apple Podcasts
🎤 Listen on Spotify
=== CONNECT WITH THE RHV TEAM ===
✭ LinkedIn ✭ Threads ✭ Bluesky ✭ X
00:00 Introduction.
05:03 "The concept of co-pay accumulators wasn't just a … PBM thought, but it also came from their customers, whether it was health plans or employer groups."
10:00 "[This is] literally a math problem based on, 'Do I spend it now? Do I spend it later?'"
11:31 What reason do employers and payers have for doing this?
15:26 "This is another mechanism for payers to push down additional cost to both the patient and now the pharma company."
19:57 EP241 with Vinay Patel.
20:33 "I don't think accumulators are really forcing Pharma to be more competitive."
22:49 How co-pay maximizers are different from co-pay accumulators.
25:57 Who doesn't like co-pay accumulators and maximizers?
28:03 How patient advocacy groups are a different model.
30:14 What is the biggest challenge facing employers right now?
Proudly Supported by
